Appeals Court Pauses An ACA Rollback
The decision temporarily blocks a lower court decision that stopped health plans from covering some preventive health care. In other news, President Joe Biden nominates National Cancer Institute Director Monica Bertagnolli to fill the long-vacant director slot at the National Institutes of Health.
The New York Times:
Appeals Court Pauses Ruling That Threatened Free Preventive Health Care
A federal appeals court on Monday temporarily blocked a lower court decision that overturned the Affordable Care Act’s requirement that all health plans fully cover certain preventive health services. The move by the U.S. Court of Appeals for the Fifth Circuit in New Orleans will put on hold a decision from March that had threatened insurance coverage for recommended services like depression screenings for teenagers and drugs that prevent transmission of H.I.V. The Justice Department had appealed the decision, and the appeals court’s stay will stand while the appeals process plays out. (Baumgaertner, 5/15)
Stat:
U.S. Supreme Court Declines To Hear 'Skinny Labeling' Case
After months of anticipation, the U.S. Supreme Court declined to hear an appeal of a lower court ruling that throws into question whether generic companies can “carve out” uses for their medicines and supply Americans with cheaper alternatives to brand-name drugs. At issue is skinny labeling, which happens when a generic company seeks regulatory approval to market its medicine for a specific use, but not other patented uses for which a brand-name drug is prescribed. For instance, a generic drug could be marketed to treat one type of heart problem, but not another. In doing so, the generic company seeks to avoid lawsuits claiming patent infringement. (Silverman, 5/15)
Stat:
Biden Nominates Monica Bertagnolli To Head NIH
President Biden on Monday officially announced that he would nominate National Cancer Institute Director Monica Bertagnolli to fill the long-vacant director slot at the National Institutes of Health. The cancer surgeon has led NCI — NIH’s largest institute — since last October and previously led Dana-Farber Cancer Institute’s surgical oncology unit. If confirmed by the Senate, she would be the second woman to lead the agency. (Owermohle, 5/15)
